daf-21 Antibody

Shipped with Ice Packs
In Stock

Description

Molecular Identity of DAF-21

DAF-21 is the C. elegans ortholog of heat shock protein 90 (HSP90), encoded by the daf-21 gene . It shares structural and functional homology with mammalian HSP90, featuring:

  • A conserved N-terminal ATP-binding domain

  • A middle domain involved in client protein interactions

  • A C-terminal dimerization region

Monoclonal antibodies against DAF-21 have enabled precise localization studies, revealing its constitutive expression in germline cells and stress-inducible expression in somatic tissues . Under heat shock, DAF-21 redistributes to the perinuclear regions of somatic cells, suggesting a role in protein quality control during stress .

Role in Longevity Regulation

DAF-21 interacts with the insulin/IGF-1 signaling pathway to modulate lifespan through FOXO transcription factor DAF-16 :

InterventionLifespan Effect (Wild-Type)MechanismCitation
daf-21 RNAi (L1 stage)20–50% reductionImpaired DAF-16A nuclear translocation
daf-21 RNAi (L4 stage)Partial reductionReduced DAF-16A target gene expression
Heat shock (35°C)Increased nuclear DAF-16ADAF-21-dependent stabilization

DAF-21 specifically regulates the A isoform of DAF-16, governing ~70% of longevity effects in daf-2 insulin receptor mutants . This isoform-specific regulation occurs upstream of nuclear import, independent of chaperone-client interactions .

Developmental Functions

  • Germline maintenance: DAF-21 antibodies localize the protein to Z2/Z3-derived germ cells under basal conditions

  • Dauer formation: Neuronal DAF-21 is required to bypass dauer arrest in adverse environments

  • Fertility: daf-21 knockdown reduces brood size by 40–60% through disrupted oogenesis

Antibody Applications

DAF-21 antibodies have been critical for:

  1. Subcellular localization: Immunostaining reveals stress-dependent redistribution from cytoplasm to perinuclear regions

  2. Protein interaction studies: Co-immunoprecipitation identifies DAF-16A as a key binding partner

  3. Functional blocking: Antibody injection phenocopies daf-21 RNAi lifespan effects

Technical Considerations

  • Specificity: Commercial anti-DAF-21 antibodies (e.g., Cell Signaling Technology #4874) show >90% homology recognition across nematode species

  • Limitations:

    • Cross-reactivity with HSP90 isoforms requires validation via RNAi controls

    • Fixation methods alter epitope accessibility in germline visualization

Future Directions

Current research leverages DAF-21 antibodies to investigate:

  • Chaperone-mediated proteostasis in neurodegenerative models

  • Intersection of heat shock response and insulin signaling in cancer biology

  • CRISPR-engineered DAF-21 mutants for structure-function analyses

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
daf-21 antibody; C47E8.5 antibody; Heat shock protein 90 antibody; Abnormal dauer formation protein 21 antibody
Target Names
daf-21
Uniprot No.

Target Background

Function
DAF-21, a molecular chaperone, plays a crucial role in the maturation, structural maintenance, and proper regulation of specific target proteins involved in various cellular processes, including cell cycle control and signal transduction. Its functional cycle is intricately linked to its ATPase activity, which likely induces conformational changes in client proteins, leading to their activation. DAF-21 dynamically interacts with diverse co-chaperones, modulating its substrate recognition, ATPase cycle, and chaperone function. In response to cellular stress, DAF-21 is upregulated in distal tissues in a pqm-1-dependent manner, preventing protein misfolding and maintaining proteostasis. By stabilizing the receptor-type guanylate cyclase daf-11 or another signal transduction component that regulates cGMP levels, DAF-21 plays a significant role in dauer formation and chemotaxis towards non-volatile and volatile attractants detected by AWC sensory neurons. Additionally, DAF-21 participates in regulating cell cycle progression at the prophase/metaphase transition during oocyte development by ensuring the activity of wee-1.3 kinase, which negatively regulates cdk-1 through phosphorylation. DAF-21 also regulates yap-1 nuclear export following heat shock treatment.
Gene References Into Functions
  1. This study reveals that a conserved tryptophan in the middle domain of DAF-21 senses the interaction with a stringent client protein and transmits this information via a cation-pi interaction with a neighboring lysine. PMID: 29662162
  2. This newentry study investigates the role of the MAP Kinase pathway and its regulator protein DAF-21 in the immune response against opportunistic pathogen P. mirabilis infection. PMID: 27072109
  3. The activity of protein phosphatase 5 towards native clients, such as the glucocorticoid receptor, is modulated by the middle and C-terminal domains of DAF-21. PMID: 26593036
  4. Suppression of misfolding in muscle cells is achieved not only by enhanced expression of DAF-21 in muscle cells but also by elevated expression of DAF-21 in intestine or neuronal cells. This cell-nonautonomous control of DAF-21 expression relies upon transcriptional feedback between somatic tissues regulated by the FoxA transcription factor PHA-4. PMID: 23746847
  5. DAF-21 appears to participate in the maintenance of muscle structures as a transiently associated diffusible factor. PMID: 21980476
  6. DAF-21 indirectly regulates the meiotic prophase/metaphase transition during oocyte development by ensuring the normal function of WEE-1.3. PMID: 16466390
  7. PA28 is likely to function in collaboration with DAF-21. PMID: 16650828

Show More

Hide All

Database Links

KEGG: cel:CELE_C47E8.5

STRING: 6239.C47E8.5.4

UniGene: Cel.17789

Protein Families
Heat shock protein 90 family
Subcellular Location
Cytoplasm, perinuclear region. Note=Perinuclear region of somatic cells.
Tissue Specificity
In the embryo comma stage, expression is strongly detected in cells of the head region and less so in other areas. In early larvae, expressed in postembryonic germ cells derived from Z2 and Z3 cells and the head region, in both hermaphrodites and males. U

Q&A

What is DAF-21 and why is it significant in aging research?

DAF-21 is the Caenorhabditis elegans homolog of heat shock protein 90 (Hsp90), a molecular chaperone that plays crucial roles in protein folding, stability, and cellular signaling. Its significance in aging research stems from its involvement in regulating longevity through the insulin/insulin-like signaling (ILS) pathway. Specifically, DAF-21 ensures proper function of DAF-16 (a FOXO transcription factor), which is a central regulator of stress resistance and longevity . Experimental evidence shows that reducing DAF-21 capacity through RNAi shortens both wild-type and daf-2 mutant (insulin-like receptor mutant) lifespan, indicating that DAF-21 is required for normal and extended lifespan .

How is DAF-21 typically detected in C. elegans research?

DAF-21 can be detected through multiple methodological approaches:

  • Antibody-based detection: Using polyclonal or monoclonal antibodies specific to DAF-21 in Western blotting and immunohistochemistry

  • Transcript analysis: Measuring mRNA levels through RT-PCR or in situ hybridization

  • Reporter constructs: Using GFP or other fluorescent protein fusions to visualize DAF-21 expression patterns

  • Phenotypic analysis: Observing characteristic phenotypes associated with DAF-21 dysfunction, such as altered lifespan, sterility, or developmental defects

For antibody-based detection, immunohistochemistry protocols typically involve dissecting adult gonads, fixing them in paraformaldehyde, permeabilizing with detergent, and staining with DAF-21-specific antibodies at dilutions ranging from 1:50 to 1:250 .

How should researchers design RNAi experiments to study DAF-21 function while avoiding developmental defects?

Designing RNAi experiments for DAF-21 requires careful timing and delivery considerations due to its essential developmental roles:

Recommended protocol based on experimental data :

RNAi Initiation PointOutcomes/EffectsRecommended Applications
Embryonic stageEmbryonic/early larval lethality; severe developmental defectsNot recommended for aging or post-developmental studies
Hatching (L1)Reduced DAF-21 capacity without lethal developmental defects; protruding vulva phenotype (~90%); mild hypomotility; sterilitySuitable for studying DAF-21's role in lifespan determination and stress response
L4 stageNo protruding vulva; reduced brood size; occasional embryonic lethality in offspringOptimal for separating developmental from adult-specific roles of DAF-21

For lifespan assays, initiating daf-21(RNAi) from hatching shortens wild-type lifespan by approximately 15-40% and daf-2 mutant lifespan by 20-50%, while treatment from L4 stage can extend daf-2 mutant lifespan . Always include hsf-1 dependent heat shock response measurements (hsp-16.2 and hsp-70 expression) to confirm successful DAF-21 knockdown .

What are the optimal conditions for DAF-21 antibody use in Western blot and immunohistochemistry?

Western Blot Protocol Optimization:

  • Sample preparation: Extract proteins from synchronized C. elegans populations using standard lysis buffer with protease inhibitors

  • Protein amount: Load 20-40μg total protein per lane

  • Recommended antibody dilution: 1:200-1:1000 (verify optimal dilution for each antibody lot)

  • Secondary antibody: Anti-rabbit IgG-HRP (1:5000-1:10000)

  • Detection method: Enhanced chemiluminescence (ECL)

Immunohistochemistry Protocol:

  • Fixation: 4% paraformaldehyde in PBS for 10-20 minutes at room temperature

  • Permeabilization: 0.1-0.5% Triton X-100 in PBS for 10 minutes

  • Blocking: 1-5% BSA or normal serum in PBS for 30-60 minutes

  • Primary antibody: Anti-DAF-21 at 1:50-1:250 dilution, overnight at 4°C

  • Secondary antibody: Anti-rabbit IgG-FITC at 1:40 dilution, 1-2 hours at room temperature

  • Nuclear counterstain: DAPI (1 μg/mL)

  • Mounting: Anti-fade mounting medium

These conditions have been empirically determined from published research and should be further optimized for specific experimental systems .

How can DAF-21 antibodies be used to investigate the isoform-specific regulation of DAF-16?

DAF-21 distinctly regulates DAF-16 isoforms, providing a unique experimental system for studying isoform-specific transcription factor regulation. To investigate this:

Methodological approach:

  • Co-immunoprecipitation assays: Use DAF-21 antibodies to pull down protein complexes, followed by Western blotting with antibodies against DAF-16A or DAF-16D/F to detect potential physical interactions.

  • Combined immunofluorescence: Perform dual staining with DAF-21 antibodies and DAF-16 isoform-specific antibodies to assess co-localization patterns.

  • Nuclear translocation assay: As demonstrated in published research, DAF-21 specifically regulates DAF-16A nuclear translocation but not DAF-16D/F . This can be monitored using:

    • GFP-tagged DAF-16 isoforms (DAF-16A::GFP, DAF-16D/F::GFP)

    • Immunostaining with isoform-specific antibodies

    • Quantitative analysis of nuclear vs. cytoplasmic fluorescence intensity

  • Transcriptional readout system: Measure the expression of isoform-specific target genes:

    • DAF-16A targets: sod-3, old-1, gst-20, scl-20

    • DAF-16D/F targets: lea-1, scl-1, col-183, R05D8.7

The research data indicates that daf-21 knockdown inhibits DAF-16A-dependent gene expression without affecting DAF-16D/F targets, providing a clear experimental readout of isoform-specific activity .

What methodological approaches can resolve contradictory findings about DAF-21's role in lifespan regulation?

Research has revealed complex, context-dependent effects of DAF-21 on lifespan. To resolve apparent contradictions in experimental findings, consider:

Recommended methodological strategies:

  • Temporal analysis: Implement precise temperature-shift experiments or inducible RNAi systems to define developmental windows when DAF-21 affects longevity.

  • Tissue-specific knockdown: Use tissue-specific promoters to drive daf-21 RNAi in specific tissues (intestine, muscle, neurons) to determine where DAF-21 function is critical for longevity.

  • Genetic interaction mapping: Systematically assess genetic interactions between daf-21 and components of longevity pathways:

    Genetic Backgrounddaf-21(RNAi) EffectResearch Implication
    Wild-typeShortened lifespanDAF-21 supports normal longevity
    daf-2(e1370)Shortened lifespan (RNAi from L1)DAF-21 required for full ILS-mediated longevity
    daf-2(e1370)Extended lifespan (RNAi from L4)DAF-21 may have age-specific functions
    daf-16(mgDf50)Partially suppressed lifespan shorteningDAF-21 acts partly through DAF-16
    daf-16a::rfp daf-2;daf-16Shortened lifespanDAF-21 specifically supports DAF-16A function
    daf-16d/f::gfp daf-2;daf-16Minimal effect on lifespanDAF-16D/F function is independent of DAF-21
  • Multi-omics approaches: Combine transcriptomics, proteomics, and metabolomics to capture system-wide changes in response to daf-21 manipulation at different life stages.

These methodological approaches address the observed differences in DAF-21's effects when manipulated at different developmental stages or in different genetic backgrounds .

What controls should be included when using DAF-21 antibodies for immunostaining?

Proper controls are essential for accurate interpretation of DAF-21 antibody staining:

Required controls:

  • Primary antibody specificity controls:

    • Negative control: Use pre-immune serum or non-specific IgG at the same concentration as primary antibody

    • Peptide competition: Pre-incubate DAF-21 antibody with excess immunizing peptide to block specific binding

    • Genetic control: Use daf-21(RNAi) or mutant samples to confirm reduced signal intensity

  • Secondary antibody controls:

    • Omit primary antibody while maintaining all other steps

    • Use isotype-matched control antibodies

  • Positive controls:

    • Tissues with known DAF-21 expression patterns (germline cells show characteristically high expression)

    • Heat-shocked samples (which should show increased DAF-21 expression)

  • Validation using multiple approaches:

    • Confirm antibody specificity using Western blot

    • Compare with in situ hybridization for daf-21 mRNA

    • Cross-validate with GFP reporter strains when available

Published data shows that DAF-21 is characteristically distributed in postembryonic germ cells derived from Z2 and Z3 cells in both hermaphrodites and males, providing a reliable positive control tissue .

How can researchers distinguish DAF-21's roles in fertility versus longevity in experimental designs?

Separating DAF-21's functions in fertility from its longevity effects requires specialized experimental approaches:

Methodological solutions:

  • Timing of intervention:

    • Implement daf-21(RNAi) at different developmental stages (L1, L4, young adult)

    • Compare phenotypic outcomes across multiple physiological processes

  • Temperature-sensitive alleles or conditional knockdown:

    • Use temperature shifts at different life stages to manipulate DAF-21 function

  • Sterile genetic backgrounds:

    • Introduce daf-21 manipulations in sterile mutant backgrounds (e.g., glp-1, fem-1)

    • This approach isolates longevity effects from fertility effects

  • Cell-specific gene manipulation:

    • Target daf-21 knockdown in reproductive tissues versus somatic tissues

    • Compare resulting phenotypes

  • Comparative measurements:

    TreatmentFertility EffectLifespan EffectMechanism Implication
    daf-21(RNAi) from L1Sterility; lack of oocytesShortened lifespanSeparate pathways affected
    daf-21(RNAi) from L4Reduced brood sizeVariable effect on lifespanPartial independence of pathways
    daf-2;daf-21(RNAi)Abolished delayed reproductionShortened lifespanIndependent effects

Research data indicates that the differential effects of daf-21(RNAi) on daf-2 lifespan appear to be independent of fertility, as both early and late RNAi treatments similarly abolished the delayed reproduction phenotype of daf-2 mutants while having opposite effects on lifespan .

How should researchers interpret contradictory results between DAF-21 antibody staining and transcriptional reporter assays?

When faced with discrepancies between antibody-based detection and transcriptional reporters:

Analytical approaches:

  • Temporal resolution analysis: Consider that protein stability and mRNA turnover rates might differ

    • DAF-21 protein may persist after transcript levels decrease

    • Sequential time-course experiments can reveal temporal relationships

  • Post-transcriptional regulation assessment:

    • Measure protein half-life through cycloheximide chase experiments

    • Investigate regulatory mechanisms like microRNA targeting

    • Use proteasome inhibitors to test degradation pathways

  • Spatiotemporal sensitivity differences:

    • Antibody sensitivity may differ from reporter brightness

    • Some tissues may have differential penetrance to antibodies versus transgene expression

  • Methodological limitations comparison:

    MethodAdvantagesLimitationsBest Applications
    DAF-21 antibodyDetects endogenous protein; Shows post-translational modificationsPotential cross-reactivity; Fixation artifactsProtein localization; Quantification
    Transcriptional reporterLive imaging; Cell-specific resolutionMay not reflect post-transcriptional regulation; Potential transgene artifactsGene expression dynamics; Cell-specific studies
    RT-PCR/qPCRQuantitative; High sensitivityNo spatial information; Measures mRNA not proteinExpression level changes; Isoform analysis

Research shows that under normal conditions, daf-21 mRNA is characteristically distributed in postembryonic germ cells, while under heat stress, expression appears throughout the body . Any discrepancy between this pattern and antibody staining should be carefully analyzed considering method-specific limitations.

What methodological considerations are important when studying DAF-21's role in cross-species comparative aging research?

Comparative aging research using DAF-21/Hsp90 across species requires specialized methodological considerations:

Recommended cross-species experimental approaches:

  • Sequence homology and functional domain analysis:

    • Perform phylogenetic analysis to establish evolutionary relationships

    • Focus on conserved functional domains (HATPase-c superfamily domain and Hsp90 protein domain)

    • Antibody selection should target conserved epitopes for cross-species reactivity

  • Complementation studies:

    • Test whether orthologs can functionally replace C. elegans DAF-21

    • Express mammalian Hsp90 in daf-21 mutant backgrounds

  • Transcriptional profiling comparison:

    • Compare downstream gene expression changes across species

    • Focus on conserved longevity pathways (FOXO/DAF-16 targets)

  • Cross-species antibody validation:

    SpeciesAntibody Cross-ReactivityRecommended DilutionKey Considerations
    C. elegans (DAF-21)Direct target1:200 (WB), 1:50 (IHC)Standard control
    Trichinella spiralis (TsDAF-21)Confirmed cross-reactivity1:100-1:200Expressed in all examined stages
    Other nematodesVariable cross-reactivityRequires validationPhylogenetic proximity determines reactivity
    Mammals (Hsp90)Limited cross-reactivityNot recommendedUse mammal-specific Hsp90 antibodies

Research on Trichinella spiralis showed that TsDAF-21 forms a monophyletic clade with other nematodes and its protein is ubiquitously expressed in newborn larvae, muscle larvae, and adult worms . This phylogenetic conservation enables some cross-species applications of DAF-21 antibodies.

How can DAF-21 antibodies be used to investigate the molecular mechanism of isoform-specific DAF-16 regulation?

To elucidate the molecular basis of DAF-21's isoform-specific regulation of DAF-16:

Advanced mechanistic investigation approaches:

  • Proximity labeling techniques:

    • BioID or TurboID fusions with DAF-21 to identify proximal proteins

    • Compare interactomes in wild-type versus stress conditions

  • Domain-specific interaction mapping:

    • Generate antibodies against specific DAF-21 domains

    • Use domain-specific antibodies in blocking experiments

    • Perform co-IP studies with domain deletion constructs

  • Structural biology approaches:

    • Employ antibodies for protein purification for structural studies

    • Use in vitro reconstitution of DAF-21 and DAF-16 isoform interactions

  • Post-translational modification analysis:

    • Phospho-specific antibodies to study DAF-16 isoform modification

    • Investigate how DAF-21 affects these modifications

Research data indicates that DAF-21 acts upstream of DAF-16A nuclear traffic, as demonstrated by experiments with the DAF-16A AM::GFP construct (with mutated AKT phosphorylation sites). Neither the quantity nor the localization of DAF-16A AM::GFP was modified by daf-21(RNAi), suggesting DAF-21 influences DAF-16A activation upstream of its nuclear import . This information provides a starting point for more detailed mechanistic studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.